Swedish Orphan Biovitrum
321,4
SEK
0 %
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
0%
+1,26%
+1,97%
+8,51%
+16,11%
+10,3%
+85,7%
+121,3%
+573,53%
Swedish Orphan Biovitrum, also known as Sobi, is an international pharmaceutical company. The company is focused on the research and development of treatments and belonging services for patients with rare diseases. The products are mainly focused on the treatment of inflammatory and genetic diseases. Sobi also markets specialized wound patches under various brands. The head office is located in Stockholm.
Læs mereMarkedsværdi
114,42 mia. SEK
Aktieomsætning
124,44 mio. SEK
Omsætning
22,12 mia.
EBIT %
18,38 %
P/E
43,03
Udbytteafkast, %
-
Finanskalender
5.2
2025
Årsrapport '24
29.4
2025
Delårsrapport Q1'25
8.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Swedish Orphan Biovitrum AB: Bulletin from Sobi's Extraordinary General Meeting (EGM)
Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools